Cara Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Tvardi Therapeutics, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, detailing proposals for director elections, executive compensation, and auditor ratification.
Cara Therapeutics is asking stockholders to vote on key proposals at its upcoming annual meeting, including increasing authorized shares and a potential reverse stock split.
Cara Therapeutics is asking stockholders to approve an increase in authorized shares and a potential reverse stock split at its upcoming annual meeting.